JK

Jeff Knox

Investor at Innospark Ventures

Boston, Massachusetts

Overview 

Jeff Knox is an Investor at Innospark Ventures in Boston, Massachusetts, with a focus on investing in life sciences startups at various stages and sectors, including drug delivery, therapeutics, and medical devices. With an MBA from MIT Sloan School of Management and experience at top organizations like Takeda and Dana-Farber Cancer Institute, Jeff has demonstrated expertise in data analysis, team leadership, and consulting within the biotechnology and healthcare industries.

Work Experience 

  • Investor

    2022 - Current

    Innospark is an early-stage venture capital firm supporting founders who put data science and AI to work solving hard problems in life sciences, healthcare, and vertical enterprise.

Innospark Ventures is a new breed of early-stage venture capital firm, investing in impact-driven AI startups in Boston/New England.

  • Co-Managing Director, Boston

    2021 - 2022

  • Lead, Operations

    2020 - 2021

    Nucleate Bio is an entrepreneurship organization enabling the formation of life science ventures. The Boston-born initiative counts more than 100 alumni teams that have gone on to raise more than $300M in outside funding, and operates in cities across the US and around the world.

a collaborative venture program enabling the formation of biotechnology companies addressing climate & sustainability challenges

  • Business Development

    2021 - 2022

    Carmine is a biotechnology company developing novel non-viral gene therapies leveraging the properties of red blood cell extracellular vesicles.

Carmine Therapeutics develops a novel type of gene therapy that utilizes extracellular vesicles produced in the laboratory.

Raised $3,400,000.00 from Huagai Capital, Cystic Fibrosis Foundation, Simcere Pharma and EVX Ventures.

  • Business Development Intern, Center for External Innovation

    2021 - 2021

    The Center for External Innovation sources, transacts and supports external ideas for creating new therapeutic options in Takeda’s areas of focus. The CEI oversees all R&D business development, venture investments, academic alliances, and externalizations, and supports M&A efforts as well.

  • MBA Intern, Binney Street Capital, Venture Capital

    2021 - 2021

    Binney Street Capital is Dana-Farber’s first-ever venture fund, capitalizing on investment opportunities created by Dana-Farber innovations and investigators.

Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research.

Raised $67,079,019.00 from Llama, Hyundai Hope On Wheels, Hyundai Hope On Wheels, Break Through Cancer, Paula and Rodger Riney Foundation, Massachusetts Life Sciences Center and Massachusetts Life Sciences Center.

  • MBA Intern

    2021 - 2021

    Lifespan Equity Partners is a private equity firm that invests in healthcare service and technology businesses that improve quality of care.

  • Associate Principal

    2020 - 2020

  • Engagement Manager

    2018 - 2020

  • Senior Consultant

    2016 - 2018

  • Consultant

    2015 - 2016

  • Associate Consultant

    2014 - 2015

    Trinity is a life sciences consultancy integrating research, analytics, and technology to better advise the commercialization of new interventions improving human health.

Trinity provides strategic and tactical insights to address the complex business questions that confront pharmaceutical, biotech.

Articles About Jeff

Relevant Websites